Atlas Trials

Elranatamab Expanded Access Protocol in Adults With Relapsed/Refractory Multiple Myeloma

Clinical trial NCT05462639 · NO_LONGER_AVAILABLE

Trial details

NCT number
NCT05462639
Sponsor
Pfizer
Status
NO_LONGER_AVAILABLE
Study type
EXPANDED_ACCESS
Multiple Myeloma

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.